Vanda Pharmaceuticals
VNDA
#8787
Rank
โ‚ฌ0.20 B
Marketcap
3,41ย โ‚ฌ
Share price
6.41%
Change (1 day)
-10.80%
Change (1 year)

EPS for Vanda Pharmaceuticals (VNDA)

EPS in 2023 (TTM): 0,26ย โ‚ฌ

According to Vanda Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -4,14ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 0,11ย โ‚ฌ a decrease over its 2021 EPS that were of 0,54ย โ‚ฌ.

EPS history for Vanda Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)0,26ย โ‚ฌ138.79%
20220,11ย โ‚ฌ-80%
20210,54ย โ‚ฌ39.53%
20200,38ย โ‚ฌ-80.18%
20191,94ย โ‚ฌ334%
20180,45ย โ‚ฌ-247.06%
2017-0,30ย โ‚ฌ-19.05%
2016-0,38ย โ‚ฌ-55.32%
2015-0,84ย โ‚ฌ-347.37%
20140,34ย โ‚ฌ-156.72%
2013-0,60ย โ‚ฌ-31.63%
2012-0,88ย โ‚ฌ172.22%
2011-0,32ย โ‚ฌ-238.46%
20100,23ย โ‚ฌ-119.7%
2009-1,18ย โ‚ฌ-31.61%
2008-1,72ย โ‚ฌ-31.32%
2007-2,51ย โ‚ฌ-99.27%
2006-346,09ย โ‚ฌ36045.14%
2005-0,96ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
5,97ย โ‚ฌ-244.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
4,69ย โ‚ฌ-213.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
0,68ย โ‚ฌ-116.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
27,57ย โ‚ฌ-766.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
0,89ย โ‚ฌ-121.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
4,04ย โ‚ฌ-197.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-3,92ย โ‚ฌ-5.18%๐Ÿ‡บ๐Ÿ‡ธ USA